TABLE 2.
Checkerboard-based representation of the cumulative effect of ethyl acetate (EA) fraction of HelS1 and antibiotic ciprofloxacin on the growth of methicillin-resistant Staphylococcus aureus (MRSA).
| Ciprofloxacin (μgmL–1) | 0.9 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0.7 | 0.059 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0.5 | 0.101 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0.3 | 0.4 | 0.32 | 0 | 0 | 0 | 0 | 0 | |
| 0.2 | 0.541 | 0.496 | 0.374 | 0.358 | 0 | 0 | 0 | |
| 0.1 | 0.689 | 0.598 | 0.402 | 0.376 | 0.296 | 0.198 | 0 | |
| 0 | 0.729 | 0.601 | 0.5 | 0.409 | 0.319 | 0.207 | 0 | |
| 0 | 3.125 | 6.25 | 12.5 | 25 | 50 | 100 | ||
|
EA extract of HELS1 (μgmL–1)
|
||||||||